Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact

Jiawen Yang; Partho Battacharya; Ruchi Singhal; Eugene S. Kandel

doi:10.18632/oncotarget.287

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Brief Reports:

Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact

Jiawen Yang, Partho Battacharya, Ruchi Singhal and Eugene S. Kandel _

PDF | HTML | How to cite

Oncotarget. 2011; 2:358-362. https://doi.org/10.18632/oncotarget.287

Metrics: PDF 2704 views | HTML 6231 views | ?

Abstract

Jiawen Yang ^1,2*, Partho Battacharya ^1,2*, Ruchi Singhal ^1*, Eugene S. Kandel¹

¹Roswell Park Cancre Institute, Department of Cell Stress Biology, Elm & Carlton St., Buffalo, NY, 142263, USA

²City Honors School, 186 East North Street, Buffalo, NY, 14204, USA

^*These authors contributed equally to this work

Keywords: XMRV, prostate cancer, CWR22, 22Rv1

Received: April 27, 2011; Accepted: May 29, 2011; Published: June 2, 2011;

Correspondence:

Eugene S. Kandel, e-mail:

Abstract

The prevalence of xenotropic murine leukemia virus-related virus (XMRV) in human population and its involvement in prostate cancer are subjects of ongoing research and debate. 22Rv1, which is a human cell line that serves as a common model of androgen-independent prostate cancer, was recently reported to carry infectious copies of XMRV. 22Rv1 was derived from a prostate cancer xenograft CWR22 that was serially passaged in immunodeficient mice. Based on the analysis of the DNA from CWR22 and 22Rv1, we present evidence against the presence of XMRV in CWR22 and, by inference, the tumor, from which CWR22 and 22Rv1 were established. While the presence of XMRV in 22Rv1 is likely to be an artifact, it may be a significant factor in determining the biological properties of this cell line. This consideration warrants additional caution for the interpretation of the relevance of the studies, which utilize this popular cell line as a model. It also invites a closer look at the sources of viral contamination in xenografts and cultured cells, as well as in the experiments that allege the presence of this virus in human cells and populations.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 287

Publication Alerts

Brief Reports:

Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact

Abstract